Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
European Radiology
Erschienen in: European Radiology 3/2019

18.09.2018 | Oncology

Quantitative assessment of mesorectal fat: new prognostic biomarker in patients with mid-to-lower rectal cancer

verfasst von: Jiyoung Yoon, Yong Eun Chung, Joon Seok Lim, Myeong-Jin Kim

Erschienen in: European Radiology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate the impact of mesorectal fat area (MFA) on oncologic outcomes in patients with mid-to-lower rectal cancer who received curative-intent surgery.

Methods

Patients with mid-to-lower rectal cancer who underwent preoperative abdominopelvic computed tomography (CT) and curative-intent surgery in 2011 were divided into two groups by tumour recurrence (group A) or no recurrence (group B) during a 5-year follow-up. Visceral fat area (VFA) and MFA were measured on preoperative CT and cutoff values were calculated using the Youden index. Univariate and multivariate regression analyses including BMI, VFA, and MFA were performed to investigate meaningful prognostic biomarkers. The Kaplan–Meier method with log-rank testing was used to validate prognostic biomarkers.

Results

Group A contained 42 patients and group B had 155 patients. Cutoff values were 25 kg/m2 for BMI, 130 cm2 for VFA, and 10 cm2 for MFA using the Youden index. On multivariate Cox regression analysis, MFA (odds ratio [OR] = 0.426, p = 0.010), TNM stage (p = 0.027), and perioperative complication grade (p = 0.028) were significantly different between groups. BMI and VFA did not show significant differences. By the Kaplan–Meier method with log-rank testing, disease-free survival (DFS) was significantly longer in patients with MFA ≥10 cm2 compared to patients with MFA <10 cm2 (p = 0.021), with no significant difference in overall survival (OS).

Conclusions

MFA was an independent biomarker for predicting DFS in patients who underwent curative-intent surgery for mid-to-lower rectal cancer.

Key Points

• Mesorectal fat area is associated with the prognosis of rectal cancer patients.
• Mesorectal fat area can be calculated easily in pre-operative CT scan.
• Predicting prognosis of the cancer patient before operation is important.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
American Institute for Cancer Research., World Cancer Research Fund (2007) Food, nutrition, physical activity and the prevention of cancer: a global perspective: a project of World Cancer Research Fund International. American Institute for Cancer Research, Washington, D.C.
2.
Chen W, Li Q, Fan Y et al (2016) Factors Predicting Difficulty of Laparoscopic Low Anterior Resection for Rectal Cancer with Total Mesorectal Excision and Double Stapling Technique. PLoS One 11:e0151773CrossRefPubMedPubMedCentral
3.
Smith RK, Broach RB, Hedrick TL, Mahmoud NN, Paulson EC (2014) Impact of BMI on postoperative outcomes in patients undergoing proctectomy for rectal cancer: a national surgical quality improvement program analysis. Dis Colon Rectum 57:687–693CrossRefPubMed
4.
Aytac E, Lavery IC, Kalady MF, Kiran RP (2013) Impact of obesity on operation performed, complications, and long-term outcomes in terms of restoration of intestinal continuity for patients with mid and low rectal cancer. Dis Colon Rectum 56:689–697CrossRefPubMed
5.
Doleman B, Mills KT, Lim S, Zelhart MD, Gagliardi G (2016) Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis. Tech Coloproctol 20:517–535CrossRefPubMed
6.
Seishima R, Okabayashi K, Hasegawa H et al (2014) Obesity was associated with a decreased postoperative recurrence of rectal cancer in a Japanese population. Surg Today 44:2324–2331CrossRefPubMed
7.
8.
9.
Singh S, Sharma AN, Murad MH et al (2013) Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 11:1399–1412 e1397CrossRefPubMed
10.
Keum N, Lee DH, Kim R, Greenwood DC, Giovannucci EL (2015) Visceral adiposity and colorectal adenomas: dose-response meta-analysis of observational studies. Ann Oncol 26:1101–1109CrossRefPubMed
11.
Cowey SL, Quast M, Belalcazar LM et al (2005) Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression. Cancer 103:2643–2653CrossRefPubMed
12.
Watanabe J, Tatsumi K, Ota M et al (2014) The impact of visceral obesity on surgical outcomes of laparoscopic surgery for colon cancer. Int J Colorectal Dis 29:343–351CrossRefPubMed
13.
Tsujinaka S, Konishi F, Kawamura YJ et al (2008) Visceral obesity predicts surgical outcomes after laparoscopic colectomy for sigmoid colon cancer. Dis Colon Rectum 51:1757–1765 discussion 1765–1757CrossRefPubMed
14.
Cakir H, Heus C, Verduin WM et al (2015) Visceral obesity, body mass index and risk of complications after colon cancer resection: A retrospective cohort study. Surgery 157:909–915CrossRefPubMed
15.
Rickles AS, Iannuzzi JC, Mironov O et al (2013) Visceral obesity and colorectal cancer: are we missing the boat with BMI? J Gastrointest Surg 17:133–143 discussion p.143CrossRefPubMed
16.
Moon HG, Ju YT, Jeong CY et al (2008) Visceral Obesity May Affect Oncologic Outcome in Patients with Colorectal Cancer. Ann Surg Oncol 15:1918–1922CrossRefPubMed
17.
Visser O, Bakx R, Zoetmulder FA et al (2007) The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam. J Surg Oncol 95:447–454CrossRefPubMed
18.
Boyle KM, Chalmers AG, Finan PJ, Sagar PM, Burke D (2009) Morphology of the mesorectum in patients with primary rectal cancer. Dis Colon Rectum 52:1122–1129CrossRefPubMed
19.
Mazeh H, Samet Y, Abu-Wasel B et al (2009) Application of a novel severity grading system for surgical complications after colorectal resection. J Am Coll Surg 208:355–361CrossRefPubMed
20.
Billingsley CC, Cansino C, O'Malley DM et al (2016) Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMI. Gynecol Oncol 140:405–408CrossRefPubMed
21.
Allen SD, Gada V, Blunt DM (2007) Variation of mesorectal volume with abdominal fat volume in patients with rectal carcinoma: assessment with MRI. Br J Radiol 80:242–247CrossRefPubMed
22.
Sprenger T, Rothe H, Becker H et al (2013) Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement. Am J Surg Pathol 37:1283–1289CrossRefPubMed
23.
Zheng YC, Tang YY, Zhou ZG et al (2004) Tumor micrometastases in mesorectal lymph nodes and their clinical significance in patients with rectal caner. World J Gastroenterol 10:3369–3373CrossRefPubMedPubMedCentral
24.
Peeters KC, Marijnen CA, Nagtegaal ID et al (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693–701CrossRefPubMed
25.
Maurer CA, Renzulli P, Kull C et al (2011) The impact of the introduction of total mesorectal excision on local recurrence rate and survival in rectal cancer: long-term results. Ann Surg Oncol 18:1899–1906CrossRefPubMed
26.
Gollins S (2010) Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer. Colorectal Dis 12(Suppl 2):2–24CrossRefPubMed
27.
Dignam JJ, Polite BN, Yothers G et al (2006) Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 98:1647–1654CrossRefPubMed
28.
Bertani E, Chiappa A, Della Vigna P et al (2014) The Impact of pelvimetry on anastomotic leakage in a consecutive series of open, laparoscopic and robotic low anterior resections with total mesorectal excision for rectal cancer. Hepatogastroenterology 61:1574–1581PubMed
Metadaten
Titel
Quantitative assessment of mesorectal fat: new prognostic biomarker in patients with mid-to-lower rectal cancer
verfasst von
Jiyoung Yoon
Yong Eun Chung
Joon Seok Lim
Myeong-Jin Kim
Publikationsdatum
18.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 3/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5723-5

Weitere Artikel der Ausgabe 3/2019

European Radiology 3/2019 Zur Ausgabe

Gastrointestinal

Radiomics nomogram for predicting the malignant potential of gastrointestinal stromal tumours preoperatively

Oncology

Amid proton transfer (APT) and magnetization transfer (MT) MRI contrasts provide complimentary assessment of brain tumors similarly to proton magnetic resonance spectroscopy imaging (MRSI)

Magnetic Resonance

Visualization of the lenticulostriate arteries at 3T using black-blood T1-weighted intracranial vessel wall imaging: comparison with 7T TOF-MRA

Chest

Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?

Neuro

Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis

Ultrasound

Development and validation of an ultrasound-based nomogram to improve the diagnostic accuracy for malignant thyroid nodules

Neu im Fachgebiet Radiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise